Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Bladder Cancer

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 24 articles:
HTML format



Single Articles


    September 2022
  1. LIU W, Shen D, Ju L, Zhang R, et al
    MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3.
    Oncogene. 2022 Sep 7. pii: 10.1038/s41388-022-02456.
    PubMed     Abstract available


    July 2022
  2. LIU F, Zhang H, Xie F, Tao D, et al
    Correction: Hsa_circ_0001361 promotes bladder cancer invasion and metastasis through miR-491-5p/MMP9 axis.
    Oncogene. 2022 Jul 7. pii: 10.1038/s41388-022-02358.
    PubMed    


    June 2022
  3. ZHENG X, Liu Z, Zhong J, Zhou L, et al
    Downregulation of HINFP induces senescence-associated secretory phenotype to promote metastasis in a non-cell-autonomous manner in bladder cancer.
    Oncogene. 2022 Jun 6. pii: 10.1038/s41388-022-02371.
    PubMed     Abstract available


    February 2022
  4. BAKER SC, Mason AS, Slip RG, Skinner KT, et al
    Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer.
    Oncogene. 2022 Feb 22. pii: 10.1038/s41388-022-02235.
    PubMed     Abstract available


    November 2021
  5. LIU XQ, Shao XR, Liu Y, Dong ZX, et al
    Tight junction protein 1 promotes vasculature remodeling via regulating USP2/TWIST1 in bladder cancer.
    Oncogene. 2021 Nov 15. pii: 10.1038/s41388-021-02112.
    PubMed     Abstract available


    October 2021
  6. REN S, Zhang N, Shen L, Lu Y, et al
    Lnc00892 competes with c-Jun to block NCL transcription, reducing the stability of RhoA/RhoC mRNA and impairing bladder cancer invasion.
    Oncogene. 2021 Oct 6. pii: 10.1038/s41388-021-02033.
    PubMed     Abstract available


  7. KOMURA K, Inamoto T, Tsujino T, Matsui Y, et al
    Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents.
    Oncogene. 2021;40:6210-6222.
    PubMed     Abstract available


    September 2021
  8. CHEN X, Chen H, Yao H, Zhao K, et al
    Turning up the heat on non-immunoreactive tumors: pyroptosis influences the tumor immune microenvironment in bladder cancer.
    Oncogene. 2021 Sep 29. pii: 10.1038/s41388-021-02024.
    PubMed     Abstract available


  9. CHEN X, Xu R, He D, Zhang Y, et al
    CD8(+) T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer.
    Oncogene. 2021 Sep 22. pii: 10.1038/s41388-021-02019.
    PubMed     Abstract available


  10. TAN P, Wang M, Zhong A, Wang Y, et al
    SRT1720 inhibits the growth of bladder cancer in organoids and murine models through the SIRT1-HIF axis.
    Oncogene. 2021 Sep 1. pii: 10.1038/s41388-021-01999.
    PubMed     Abstract available


    March 2021
  11. ZHENG R, Du M, Ge Y, Gao F, et al
    Identification of low-frequency variants of UGT1A3 associated with bladder cancer risk by next-generation sequencing.
    Oncogene. 2021 Mar 3. pii: 10.1038/s41388-021-01672.
    PubMed     Abstract available


    February 2021
  12. YAN Q, Zeng P, Zhou X, Zhao X, et al
    RBMX suppresses tumorigenicity and progression of bladder cancer by interacting with the hnRNP A1 protein to regulate PKM alternative splicing.
    Oncogene. 2021 Feb 9. pii: 10.1038/s41388-021-01666.
    PubMed     Abstract available


    January 2021
  13. XIONG Y, Ju L, Yuan L, Chen L, et al
    KNSTRN promotes tumorigenesis and gemcitabine resistance by activating AKT in bladder cancer.
    Oncogene. 2021 Jan 15. pii: 10.1038/s41388-020-01634.
    PubMed     Abstract available


    December 2020
  14. ROSE M, Maurer A, Wirtz J, Bleilevens A, et al
    Correction: EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer.
    Oncogene. 2020 Dec 1. pii: 10.1038/s41388-020-01534.
    PubMed     Abstract available


    October 2020
  15. JIA Y, Ding X, Zhou L, Zhang L, et al
    Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1.
    Oncogene. 2020 Oct 29. pii: 10.1038/s41388-020-01486.
    PubMed     Abstract available


  16. JIN Y, Zhou Y, Deng W, Wang Y, et al
    Genome-wide profiling of BK polyomavirus integration in bladder cancer of kidney transplant recipients reveals mechanisms of the integration at the nucleotide level.
    Oncogene. 2020 Oct 13. pii: 10.1038/s41388-020-01502.
    PubMed     Abstract available


    September 2020
  17. ROSE M, Maurer A, Wirtz J, Bleilevens A, et al
    EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer.
    Oncogene. 2020 Sep 25. pii: 10.1038/s41388-020-01465.
    PubMed     Abstract available


    August 2020
  18. VANTAKU V, Putluri V, Bader DA, Maity S, et al
    Correction: Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.
    Oncogene. 2020 Aug 17. pii: 10.1038/s41388-020-1283.
    PubMed     Abstract available


    March 2020
  19. CHANDRASHEKAR DS, Chakravarthi BVSK, Robinson AD, Anderson JC, et al
    Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression.
    Oncogene. 2020 Mar 30. pii: 10.1038/s41388-020-1275.
    PubMed     Abstract available


  20. LIU X, Cui J, Gong L, Tian F, et al
    The CUL4B-miR-372/373-PIK3CA-AKT axis regulates metastasis in bladder cancer.
    Oncogene. 2020 Mar 3. pii: 10.1038/s41388-020-1236.
    PubMed     Abstract available


    December 2019
  21. LIU HJ, Lam HC, Baglini CV, Nijmeh J, et al
    Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor beta (RARbeta).
    Oncogene. 2019;38:7367-7383.
    PubMed     Abstract available


    November 2019
  22. YANG R, Xu J, Hua X, Tian Z, et al
    Overexpressed miR-200a promotes bladder cancer invasion through direct regulating Dicer/miR-16/JNK2/MMP-2 axis.
    Oncogene. 2019 Nov 26. pii: 10.1038/s41388-019-1120.
    PubMed     Abstract available


  23. LIU F, Zhang H, Xie F, Tao D, et al
    Hsa_circ_0001361 promotes bladder cancer invasion and metastasis through miR-491-5p/MMP9 axis.
    Oncogene. 2019 Nov 8. pii: 10.1038/s41388-019-1092.
    PubMed     Abstract available


    October 2019
  24. OSEI-AMPONSA V, Buckwalter JM, Shuman L, Zheng Z, et al
    Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancer.
    Oncogene. 2019 Oct 21. pii: 10.1038/s41388-019-1063.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: